Hans Herfarth

About Hans Herfarth

Hans Herfarth, With an exceptional h-index of 76 and a recent h-index of 44 (since 2020), a distinguished researcher at University of North Carolina at Chapel Hill, specializes in the field of Inflammatory bowel diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Factors Associated With Performing Ileal Pouch-Anal Anastomosis After Total Colectomy for Ulcerative Colitis

P1142 Antibiotic use in the twelve months prior to ileal pouch-anal anastomosis increases the risk for pouchitis: A population-based Danish cohort study

Inflammatory bowel disease patients in the ambulatory setting commonly screen positive for malnutrition

Dysplasia Detection in Inflammatory Bowel Disease: An Updated Meta-Analysis With Effect

Antibiotic use in the 12 months prior to ileal pouch-anal anastomosis increases the risk for pouchitis

Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry

The Safety of Dilation of Ileoanal Strictures With Mechanical or Balloon Dilation Is Similar Among Patients After Ileal Pouch–Anal Anastomosis

What’s UP with Ulcerative Proctitis?: It’s Not Always What You Think

Hans Herfarth Information

University

Position

___

Citations(all)

21949

Citations(since 2020)

7181

Cited By

18488

hIndex(all)

76

hIndex(since 2020)

44

i10Index(all)

205

i10Index(since 2020)

134

Email

University Profile Page

Google Scholar

Hans Herfarth Skills & Research Interests

Inflammatory bowel diseases

Top articles of Hans Herfarth

Factors Associated With Performing Ileal Pouch-Anal Anastomosis After Total Colectomy for Ulcerative Colitis

Diseases of the Colon & Rectum

2024/1/25

P1142 Antibiotic use in the twelve months prior to ileal pouch-anal anastomosis increases the risk for pouchitis: A population-based Danish cohort study

Journal of Crohn's and Colitis

2024/1/1

Inflammatory bowel disease patients in the ambulatory setting commonly screen positive for malnutrition

Gastro Hep Advances

2024/1/1

Dysplasia Detection in Inflammatory Bowel Disease: An Updated Meta-Analysis With Effect

2024/4/1

Hans Herfarth
Hans Herfarth

H-Index: 37

Antibiotic use in the 12 months prior to ileal pouch-anal anastomosis increases the risk for pouchitis

Clinical Gastroenterology and Hepatology

2024/3/29

Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry

Clinical and translational gastroenterology

2024/3/1

The Safety of Dilation of Ileoanal Strictures With Mechanical or Balloon Dilation Is Similar Among Patients After Ileal Pouch–Anal Anastomosis

Inflammatory Bowel Diseases

2024/2/1

What’s UP with Ulcerative Proctitis?: It’s Not Always What You Think

Digestive Diseases and Sciences

2024/1/28

780 ANTI-TNF IN COMBINATION WITH LOW DOSE METHOTREXATE OUTPERFORMS ANTI-TNF MONOTHERAPY IN PATIENTS WITH PEDIATRIC CROHN'S DISEASE INITIATING ADALIMUMAB BUT NOT INFLIXIMAB

Gastroenterology

2023/5/1

Sa1824 RATE OF COLECTOMY INCREASES WITHIN TWELVE MONTHS OF SEQUENTIAL THERAPY FOR ULCERATIVE COLITIS

Gastroenterology

2023/5/1

286 SMART SAMPLING TOILET-A POTENTIAL NEW AUTOMATED SYSTEM FOR COLLECTING FECAL CALPROTECTIN SAMPLES

Gastroenterology

2023/5/1

Hans Herfarth
Hans Herfarth

H-Index: 37

Sonia Grego
Sonia Grego

H-Index: 16

The “Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)” project: a protocol for the development of the core outcome domain set for trials …

Archives of Dermatological Research

2023/5

Oral vs Intravenous Discharge Antibiotic Regimens in the Management of Intra-abdominal Abscesses in Penetrating Crohn’s Disease

Inflammatory Bowel Diseases

2023/12/27

EFFICACY OF UPADACITINIB IN PATIENTS PREVIOUSLY TREATED WITH TOFACITINIB FOR THE MANAGEMENT OF ULCERATIVE COLITIS

Gastroenterology

2023/4/1

Hans Herfarth
Hans Herfarth

H-Index: 37

Animesh Jain
Animesh Jain

H-Index: 6

S1120 Vedolizumab Is Effective for the Treatment of Chronic Inflammatory Conditions of the Pouch in a Prospective Multicenter Study

Official journal of the American College of Gastroenterology| ACG

2023/10/1

Chelsea Anderson
Chelsea Anderson

H-Index: 13

Hans Herfarth
Hans Herfarth

H-Index: 37

S877 Diagnosis of Inflammatory Bowel Disease Associated Peripheral Arthritis: A Systematic Review

2023/10/1

Anti-integrin αvβ6 autoantibodies are a novel biomarker that antedate ulcerative colitis

Gastroenterology

2023/4/1

S895 Disease Extension in Patients With Limited Ulcerative Colitis at Diagnosis is Not Associated With Increased Risk of Pouchitis in the First 2 Years After Ileal Pouch-Anal …

Official journal of the American College of Gastroenterology| ACG

2023/10/1

Michael Dunn
Michael Dunn

H-Index: 10

Hans Herfarth
Hans Herfarth

H-Index: 37

Tofacitinib response in ulcerative colitis (TOUR): early response after initiation of tofacitinib therapy in a real-world setting

Inflammatory bowel diseases

2023/4/1

P547 Rate of Colectomy Increases within Twelve Months of Sequential Therapy for Ulcerative Colitis

Journal of Crohn's and Colitis

2023/2/1

See List of Professors in Hans Herfarth University(University of North Carolina at Chapel Hill)

Co-Authors

academic-engine